Skip to main content
logo
Crinetics Pharmaceuticals, Inc. (CRNX)
NASDAQ: CRNX · Real-Time Price · USD
34.00
+0.27 (0.80%)
Sep 12, 2025, 4:00 PM EDT - Market closed

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Novel Therapeutics
1.04M
Log In
Log In
Log In
Log In
Upgrade
Novel Therapeutics Growth
-74.11%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
United States
1.04M
Log In
Log In
Log In
Log In
Upgrade
United States and Australia
-
Log In
Log In
Log In
Log In
Upgrade
United States and Australia Growth
-
Log In
Log In
Log In
Log In
Upgrade